









Mercado
/
Acciones
/
nasdaq-qdel
/

QuidelOrtho Corp

QDEL

29.530USD

+0.610+2.11%

Cierre 09/16, 16:00（ET）Cotizaciones retrasadas 15 min

2.00BCap. mercado

PérdidaP/E TTM



QuidelOrtho Corp

29.530

+0.610+2.11%

Descripción general Compañía Finanzas Análisis

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Información de la empresa

Símbolo de cotizaciónQDEL

Nombre de la empresaQuidelOrtho Corp

Fecha de salida a bolsaFeb 01, 1991

Director ejecutivoMr. Brian J. Blaser

Número de empleados6600

Tipo de seguridadOrdinary Share

Fin del año fiscalFeb 01

Dirección9975 Summers Ridge Road

CiudadSAN DIEGO

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal92121

Teléfono18585521100

Sitio Webhttps://www.quidelortho.com/

Símbolo de cotizaciónQDEL

Fecha de salida a bolsaFeb 01, 1991

Director ejecutivoMr. Brian J. Blaser

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.21K

+25.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Mr. Brian J. Blaser

President, Chief Executive Officer, Director

11.45K

Mr. John R. Chiminski

Independent Director

2.52K

Sergio Gadaleta

Senior Vice President - Clinical and Regulatory Affairs

Devon Burek

Senior Vice President - Global Quality

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.21K

+25.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Labs

373.10M

53.85%

Point-of-Care

170.80M

24.65%

Immunohematology

128.50M

18.55%

Donor Screening

12.80M

1.85%

Molecular Diagnostic Solutions

7.60M

1.10%

Por regiónUSD

Nombre

Ganancia

Proporción

North America

406.70M

58.70%

Other

122.20M

17.64%

EMEA

88.90M

12.83%

China

75.00M

10.83%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Labs

373.10M

53.85%

Point-of-Care

170.80M

24.65%

Immunohematology

128.50M

18.55%

Donor Screening

12.80M

1.85%

Molecular Diagnostic Solutions

7.60M

1.10%

Estadísticas de accionistas

Actualizado: vie., 15 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

T. Rowe Price Investment Management, Inc.

16.40%

BlackRock Institutional Trust Company, N.A.

13.67%

The Vanguard Group, Inc.

11.44%

Rubric Capital Management LP

6.83%

State Street Global Advisors (US)

3.98%

Otro

47.69%

Accionistas

Proporción

T. Rowe Price Investment Management, Inc.

16.40%

BlackRock Institutional Trust Company, N.A.

13.67%

The Vanguard Group, Inc.

11.44%

Rubric Capital Management LP

6.83%

State Street Global Advisors (US)

3.98%

Otro

47.69%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

66.33%

Investment Advisor/Hedge Fund

32.08%

Hedge Fund

14.79%

Research Firm

2.12%

Pension Fund

1.25%

Individual Investor

0.92%

Private Equity

0.69%

Bank and Trust

0.65%

Sovereign Wealth Fund

0.52%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

684

78.51M

115.63%

-21.42M

2025Q1

726

76.59M

113.26%

-21.60M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

2023Q2

860

68.99M

103.61%

-6.94M

2023Q1

894

68.68M

103.29%

-6.80M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

T. Rowe Price Investment Management, Inc.

11.45M

16.93%

+208.36K

+1.85%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

7.55M

11.17%

-233.81K

-3.00%

Mar 31, 2025

The Vanguard Group, Inc.

6.72M

9.94%

-77.05K

-1.13%

Mar 31, 2025

Rubric Capital Management LP

6.14M

9.08%

+590.00K

+10.63%

Mar 31, 2025

State Street Global Advisors (US)

2.19M

3.24%

-83.38K

-3.67%

Mar 31, 2025

Fidelity Management & Research Company LLC

1.26M

1.86%

+7.91K

+0.63%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.82M

2.69%

+600.34K

+49.32%

Mar 31, 2025

D. E. Shaw & Co., L.P.

1.34M

1.99%

-385.59K

-22.31%

Mar 31, 2025

American Century Investment Management, Inc.

1.59M

2.35%

+473.09K

+42.41%

Mar 31, 2025

AQR Capital Management, LLC

2.66M

3.93%

+1.85M

+230.30%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 6 de sep

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.76%

Invesco S&P SmallCap Health Care ETF

1.43%

SPDR S&P 600 Small Cap Value ETF

0.29%

iShares S&P Small-Cap 600 Value ETF

0.29%

Avantis US Small Cap Value ETF

0.23%

iShares U.S. Medical Devices ETF

0.22%

VictoryShares US Small Mid Cap Value Momentum ETF

0.18%

Invesco S&P SmallCap 600 Revenue ETF

0.18%

Avantis US Small Cap Equity ETF

0.17%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.16%

SPDR S&P Health Care Equipment ETF

Proporción1.76%

Invesco S&P SmallCap Health Care ETF

Proporción1.43%

SPDR S&P 600 Small Cap Value ETF

Proporción0.29%

iShares S&P Small-Cap 600 Value ETF

Proporción0.29%

Avantis US Small Cap Value ETF

Proporción0.23%

iShares U.S. Medical Devices ETF

Proporción0.22%

VictoryShares US Small Mid Cap Value Momentum ETF

Proporción0.18%

Invesco S&P SmallCap 600 Revenue ETF

Proporción0.18%

Avantis US Small Cap Equity ETF

Proporción0.17%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

Proporción0.16%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

